Among the polymorphisms determining aggressive CLL, the CDKN1Brs34330CC genotype appears to be the only exception, as it is a genetic variant associated with enhanced CDKN1B promoter activity and protein levels, which also emphasizes the significant role of arrested lymphocyte accumulation in CLL progression [47]. Here, CDKN1B is linked to B-cell chronic lymphocytic leukemia.